SBFM
Sunshine Biopharma Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$0.90
+6.98%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$0.82
From 52W high−95.91%
Volume157458.00
Market cap$3.49M
P/E (TTM)—
P/S (TTM)0.1x
Div yield—
Key dataSep 18, 2026
Open
$0.82
From 52W high
−95.91%
Volume
157458.00
Market cap
$3.49M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
1.8x
P/E (TTM)
—
RSI (14)
27.0
MomentumView details →
1D Return
+6.98%
YTD Return
−92.91%
SummaryUpdated Jun 1, 2026
Sunshine Biopharma, Inc. (NASDAQ:SBFM) is a Canadian pharmaceutical and nutritional supplement company founded and headquartered in Pointe-Claire, Canada. The company went public on February 15, 2022, representing a relatively recent entrant to the public markets. Sunshine Biopharma operates as a dual-focus enterprise, combining early-stage anticancer drug development with an established nutritional supplement business that generates the majority of its current revenue.
Similar companies
Latest newsMore news →
Sunshine Biopharma Inc. advanced its lead Coronavirus drug candidate into IND-enabling studies.4d agoHealth Canada approved Sunshine Biopharma's generic Atenolol tablets (25mg, 50mg, 100mg) for the Canadian market to treat and manage cardiovascular conditions.20d agoSunshine Biopharma Inc. received regulatory approval to launch its 2mg generic Dienogest tablets in Canada.47d ago